{"id":5311,"date":"2019-05-29T05:08:54","date_gmt":"2019-05-29T05:08:54","guid":{"rendered":"http:\/\/financeintellect.com\/home-page\/home\/?p=5311"},"modified":"2019-05-29T05:19:12","modified_gmt":"2019-05-29T05:19:12","slug":"sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter","status":"publish","type":"post","link":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/","title":{"rendered":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter"},"content":{"rendered":"<p style=\"text-align: justify;\">Drug major Sun Pharmaceutical Industries\u00a0on Tuesday recorded a 53% decline in consolidated net profit at\u00a0<span class=\"webrupee\">\u20b9<\/span>636 crore for the fourth quarter ended on March 31, 2019.<\/p>\n<p style=\"text-align: justify;\">The company had posted a net profit of\u00a0<span class=\"webrupee\">\u20b9<\/span>1,343 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.<\/p>\n<p style=\"text-align: justify;\">However, the consolidated total revenue from operations rose 3% to\u00a0<span class=\"webrupee\">\u20b9<\/span>7,164 crore as opposed to\u00a0<span class=\"webrupee\">\u20b9<\/span>6,977 crore in Q418.<\/p>\n<p style=\"text-align: justify;\">For the fiscal year ended March this year, the net profit of the company was at\u00a0<span class=\"webrupee\">\u20b9<\/span>2,665.42 crore. It was\u00a0<span class=\"webrupee\">\u20b9<\/span>2,095.70 crore for the previous fiscal year.<\/p>\n<p style=\"text-align: justify;\">Consolidated revenue from operations of the company was at<span class=\"webrupee\">\u20b9<\/span>28,686.28 crore for the fiscal year ended March 2019. It was<span class=\"webrupee\">\u20b9<\/span>26,065.94 crore in the previous fiscal.<\/p>\n<p style=\"text-align: justify;\">The company&#8217;s board recommended dividend of\u00a0<span class=\"webrupee\">\u20b9<\/span>2.75 per share.<\/p>\n<p style=\"text-align: justify;\">As reported by <em>Business Today<\/em>, Dilip Shanghvi, Managing Director of the Company said that despite one-time impact for India business, the full year sales have grown by double digits. They continue to focus on executing our global specialty strategy. Ilumya is hoped to gain traction in US in FY20 while Cequa launch is expected in the coming months. At the same time, Sun Pharma is strengthening its core operations, optimizing the cost structure and enhancing its overall efficiencies.<\/p>\n<p style=\"text-align: justify;\">Shares of Sun Pharmaceutical Industries closed at\u00a0<span class=\"webrupee\">\u20b9<\/span>412.90 on BSE, down 0.43 per cent from the previous close.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Drug major Sun Pharmaceutical Industries\u00a0on Tuesday recorded a 53% decline in consolidated net profit at\u00a0\u20b9636 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit of\u00a0\u20b91,343 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE. However, the consolidated total [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4729,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8],"tags":[3956,3827,454],"class_list":["post-5311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india-inc","tag-pharmaceutical-industry","tag-quarterly-results","tag-sun-pharma"],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect\" \/>\n<meta property=\"og:description\" content=\"Drug major Sun Pharmaceutical Industries\u00a0on Tuesday recorded a 53% decline in consolidated net profit at\u00a0\u20b9636 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit of\u00a0\u20b91,343 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE. However, the consolidated total [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\" \/>\n<meta property=\"og:site_name\" content=\"Finance Intellect\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-29T05:08:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-29T05:19:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"426\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Team Finance Intellect\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Team Finance Intellect\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\"},\"author\":{\"name\":\"Team Finance Intellect\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e\"},\"headline\":\"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter\",\"datePublished\":\"2019-05-29T05:08:54+00:00\",\"dateModified\":\"2019-05-29T05:19:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\"},\"wordCount\":227,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg\",\"keywords\":[\"Pharmaceutical Industry\",\"quarterly results\",\"Sun Pharma\"],\"articleSection\":[\"India Inc\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\",\"url\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\",\"name\":\"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect\",\"isPartOf\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg\",\"datePublished\":\"2019-05-29T05:08:54+00:00\",\"dateModified\":\"2019-05-29T05:19:12+00:00\",\"author\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e\"},\"breadcrumb\":{\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage\",\"url\":\"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg\",\"contentUrl\":\"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg\",\"width\":640,\"height\":426},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/financeintellect.com\/home-page\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#website\",\"url\":\"https:\/\/financeintellect.com\/home-page\/home\/\",\"name\":\"Finance Intellect\",\"description\":\"Get business and finance insights\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/financeintellect.com\/home-page\/home\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e\",\"name\":\"Team Finance Intellect\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4c0a180f6df33c7efda4a01bbf6d8981f70509af7fcc506a312b85cf5162f186?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4c0a180f6df33c7efda4a01bbf6d8981f70509af7fcc506a312b85cf5162f186?s=96&d=mm&r=g\",\"caption\":\"Team Finance Intellect\"},\"url\":\"https:\/\/financeintellect.com\/home-page\/home\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/","og_locale":"en_US","og_type":"article","og_title":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect","og_description":"Drug major Sun Pharmaceutical Industries\u00a0on Tuesday recorded a 53% decline in consolidated net profit at\u00a0\u20b9636 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit of\u00a0\u20b91,343 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE. However, the consolidated total [&hellip;]","og_url":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/","og_site_name":"Finance Intellect","article_published_time":"2019-05-29T05:08:54+00:00","article_modified_time":"2019-05-29T05:19:12+00:00","og_image":[{"width":640,"height":426,"url":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","type":"image\/jpeg"}],"author":"Team Finance Intellect","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Team Finance Intellect","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#article","isPartOf":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/"},"author":{"name":"Team Finance Intellect","@id":"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e"},"headline":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter","datePublished":"2019-05-29T05:08:54+00:00","dateModified":"2019-05-29T05:19:12+00:00","mainEntityOfPage":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/"},"wordCount":227,"commentCount":0,"image":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage"},"thumbnailUrl":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","keywords":["Pharmaceutical Industry","quarterly results","Sun Pharma"],"articleSection":["India Inc"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/","url":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/","name":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter - Finance Intellect","isPartOf":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage"},"image":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage"},"thumbnailUrl":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","datePublished":"2019-05-29T05:08:54+00:00","dateModified":"2019-05-29T05:19:12+00:00","author":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e"},"breadcrumb":{"@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#primaryimage","url":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","contentUrl":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","width":640,"height":426},{"@type":"BreadcrumbList","@id":"https:\/\/financeintellect.com\/home-page\/home\/sun-pharma-q4-profit-dropped-53-to-rs-635-9-crore-for-the-march-quarter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/financeintellect.com\/home-page\/home\/"},{"@type":"ListItem","position":2,"name":"Sun Pharma Q4 profit dropped 53% to Rs 635.9 crore for the March quarter"}]},{"@type":"WebSite","@id":"https:\/\/financeintellect.com\/home-page\/home\/#website","url":"https:\/\/financeintellect.com\/home-page\/home\/","name":"Finance Intellect","description":"Get business and finance insights","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/financeintellect.com\/home-page\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/8b5a59fca13673b990c789631416f48e","name":"Team Finance Intellect","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/financeintellect.com\/home-page\/home\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4c0a180f6df33c7efda4a01bbf6d8981f70509af7fcc506a312b85cf5162f186?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4c0a180f6df33c7efda4a01bbf6d8981f70509af7fcc506a312b85cf5162f186?s=96&d=mm&r=g","caption":"Team Finance Intellect"},"url":"https:\/\/financeintellect.com\/home-page\/home\/author\/admin\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/financeintellect.com\/wp-content\/uploads\/2019\/04\/close-up-1853400_640.jpg","_links":{"self":[{"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/posts\/5311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/comments?post=5311"}],"version-history":[{"count":1,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/posts\/5311\/revisions"}],"predecessor-version":[{"id":5312,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/posts\/5311\/revisions\/5312"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/media\/4729"}],"wp:attachment":[{"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/media?parent=5311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/categories?post=5311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/financeintellect.com\/home-page\/home\/wp-json\/wp\/v2\/tags?post=5311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}